Shanghai MicuRx Pharmaceutical's Phase 1 Trial for Non-Tuberculous Mycobacteria Drug Gets China Nod

MT NewswiresJan 6 03:48 ET

Some Shanghai MicuRx Pharmaceutical Co., Ltd. (SHSE:688373) Shareholders Look For Exit As Shares Take 25% Pounding

Simply Wall StJan 3 18:32 ET

Mengke Pharmaceutical (688373.SH): The clinical trial application for MRX-5 has been approved.

Mengke Pharmaceutical (688373.SH) announced that the company recently received a notice from the National Medical Products Administration regarding MRX...

Zhitong FinanceJan 3 02:34 ET

Express News | FDA Grants Orphan Drug Designation to Micurx's Mrx-5 for Ntm Infections

ReutersJan 1 23:52 ET

FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections

PR NewswireJan 1 23:52 ET

Shanghai MicuRx Pharmaceutical (SHSE:688373) Has Debt But No Earnings; Should You Worry?

Simply Wall StDec 17, 2024 19:49 ET